Evidence map›Paper›PMID 25847244›Full record

ArticleThe Journal of biological chemistry2015

Histone Chaperone HIRA in Regulation of Transcription Factor RUNX1.

Aditi Majumder, Khaja Mohieddin Syed, Sunu Joseph, Peter J Scambler, Debasree Dutta

Open access · hybridAbstract read
In one paragraph

Article in The Journal of biological chemistry, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 22 papers.

0numbers the graph read from it
0cells of the map it votes in
22citing papers in PubMed
1.9field-weighted citation impact, top 16% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

22 citing papers in PubMed, 29 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Article
  5. Review
  6. Article
  7. Histone Chaperones as Cardinal Players in Development.Frontiers in cell and developmental biology · 2022
    Review
  8. Article
  9. Article
  10. Review
  11. Article
  12. Chaperones and Beyond as Key Players in Pluripotency Maintenance.Frontiers in cell and developmental biology · 2019
    Review
  13. Article
  14. Molecular genetics of 22q11.2 deletion syndrome.American journal of medical genetics. Part A · 2018
    Review
  15. Article
  16. Article
  17. Review
  18. Review
  19. Article
  20. Specification and function of hemogenic endothelium during embryogenesis.Cellular and molecular life sciences : CMLS · 2016
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 1 institution in 1 country.

Aditi MajumderFrom the Cancer Research Program, Rajiv Gandhi Centre for Biotechnology, Thycaud PO, Poojappura, Thiruvananthapuram, 695 014 Kerala, India and.
Khaja Mohieddin SyedFrom the Cancer Research Program, Rajiv Gandhi Centre for Biotechnology, Thycaud PO, Poojappura, Thiruvananthapuram, 695 014 Kerala, India and.
Sunu JosephFrom the Cancer Research Program, Rajiv Gandhi Centre for Biotechnology, Thycaud PO, Poojappura, Thiruvananthapuram, 695 014 Kerala, India and.
Peter J Scamblerthe Institute of Child Health, University College of London, London WC1E 6BT, United Kingdom.
Debasree DuttaFrom the Cancer Research Program, Rajiv Gandhi Centre for Biotechnology, Thycaud PO, Poojappura, Thiruvananthapuram, 695 014 Kerala, India and debasreedutta@rgcb.res.in.
University College London · GB

Funding

British Heart Foundation PG/15/6/31211British Heart Foundation RG/10/13/28570British Heart Foundation RG/15/13/28570
6 · The paper itself

Abstract

RUNX1 (Runt-related transcription factor 1) is indispensable for the generation of hemogenic endothelium. However, the regulation of RUNX1 during this developmental process is poorly understood. We investigated the role of the histone chaperone HIRA (histone cell cycle regulation-defective homolog A) from this perspective and report that HIRA significantly contributes toward the regulation of RUNX1 in the transition of differentiating mouse embryonic stem cells from hemogenic to hematopoietic stage. Direct interaction of HIRA and RUNX1 activates the downstream targets of RUNX1 implicated in generation of hematopoietic stem cells. At the molecular level, HIRA-mediated incorporation of histone H3.3 variant within the Runx1 +24 mouse conserved noncoding element is essential for the expression of Runx1 during endothelial to hematopoietic transition. An inactive chromatin at the intronic enhancer of Runx1 in absence of HIRA significantly repressed the transition of cells from hemogenic to hematopoietic fate. We expect that the HIRA-RUNX1 axis might open up a novel approach in understanding leukemogenesis in future.

Indexed as

Gene Expression RegulationAnimalsBlotting, WesternCell Cycle ProteinsCell DifferentiationCell ProliferationCells, CulturedChromatin ImmunoprecipitationCore Binding Factor Alpha 2 SubunitEmbryo, MammalianEndothelium, VascularFlow CytometryFluorescent Antibody TechniqueHematopoiesisHematopoietic Stem CellsHistone ChaperonesCell Cycle ProteinsCore Binding Factor Alpha 2 SubunitHira protein, mouseHistone ChaperonesRNA, MessengerRunx1 protein, mouseTranscription FactorsH3.3 varianthematopoiesishematopoietic precursorhematopoietic stem cellshistonehistone chaperonetranscription factor

Identifiers

PMID25847244
PMCPMC4505562
OpenAlexW2069966979

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.